JANSSEN BIOTECH Overview
Upcoming Projects (JANSSEN BIOTECH)
-
Don’t see a project related to the company you care about? Create your own!
Upcoming & Overdue Catalysts (JANSSEN BIOTECH)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (JANSSEN BIOTECH)
-
Janssen's (JNJ) Stelara Approved by European Commission for Adults with Moderately to Severely Active Crohn's Disease
Tickers: JNJ, Janssen Biotech
Occurred on: Nov 11, 2016 -
U.S. FDA Approves IMBRUVICA (ibrutinib) for First-line Treatment of Chronic Lymphocytic Leukemia
Tickers: JNJ, ABBV, Janssen Biotech
Occurred on: Mar 04, 2016
Strategic Initiatives (JANSSEN BIOTECH)
-
Janssen's (JNJ) Codman Neurosurgery Business Acquired by Integra (IART) for $1.045B in Cash
Tickers: IART, JNJ, Janssen Biotech
Announcement Date: Feb 15, 2017
